PitchSend

Investor Presentaiton

Financial targets Raised guidance for full year 2021 Mid-term guidance 2021 guidance Promising structural industry trends Market position with 20-25% market share Established and long-standing customer base Strong H1 2021 performance Favorable environment, incl COVID Enhanced capacity needs Mid-term guidance unchanged Growth in low teens with adjusted EBITDA margin of around 30% GLOBAL SUPPORT FOR A QUALITY SOLUTION 18 Revenue growth Adj. EBITDA margin ~25% previously 16-18% ~32% previously ~28% Capex as % of Revenue >20% previously ~17% PolyPeptide GROUP

View entire presentation